Psoriatic arthritis: epidemiology, clinical features, course, and outcome

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2005-02-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ard.2004.032482PMID 15708927PMCID PMC1766874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 yearKavanaugh A, for the IMPACT Study Group (UCSD, San Diego, Calif; et al) Ann Rheum Dis 65:1038–1043, 2006§

  2007cited by this paper
• Classification and diagnostic criteria for psoriatic arthritis

  2005cited by this paper
• Genetic epidemiology of psoriasis and psoriatic arthritis

  2005cited by this paper
• Kelley's Textbook of Rheumatology

  2004cited by this paper
• Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis

  2004cited by this paper
• Reduced functional performance in the lower extremity predicted radiographic knee osteoarthritis five years later

  2004cited by this paper
• Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial.

  2004cited by this paper
• Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression.

  2004cited by this paper
• A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience.

  2003cited by this paper
• Radiography in the assessment of musculoskeletal conditions.

  2003cited by this paper
• Prevalence of Joint Disease in Patients with Psoriasis

  2003cited by this paper
• Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey.

  2003cited by this paper
• A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis

  2003cited by this paper
• Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study.

  2003cited by this paper
• Annual incidence of inflammatory joint diseases in a population based study in southern Sweden

  2002cited by this paper
• Clinical features of psoriatic arthritis.

  2002cited by this paper
• Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study.

  2002cited by this paper
• Remission in psoriatic arthritis.

  2001cited by this paper
• Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis.

  2001cited by this paper
• Comparison of disability and quality of life in rheumatoid and psoriatic arthritis.

  2001cited by this paper
• Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis.

  2001cited by this paper
• The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991.

  2000cited by this paper
• Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.

  2000cited by this paper
• Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis.

  1999cited by this paper
• Progression in psoriatic arthritis: role of time varying clinical indicators.

  1999cited by this paper
• Psoriatic Arthritis

  1998cited by this paper
• Clinical aspects of the spondyloarthropathies.

  1998cited by this paper
• Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

  1998cited by this paper
• HLA markers and progression in psoriatic arthritis.

  1998cited by this paper
• Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis.

  1998cited by this paper
• Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis.

  1997cited by this paper
• Toe dactylitis in patients with spondyloarthropathy: assessment by magnetic resonance imaging.

  1997cited by this paper
• Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death.

  1997cited by this paper
• Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study.

  1996cited by this paper
• Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model.

  1995cited by this paper
• A modified version of the Health Assessment Questionnaire (HAQ) for psoriatic arthritis.

  1995cited by this paper
• Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification.

  1995cited by this paper
• Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease.

  1994cited by this paper
• Psoriatic arthritis: a clinical, radiological and genetic study of 58 Italian patients.

  1994cited by this paper
• Classification of clinical subsets in psoriatic arthritis.

  1994cited by this paper
• Psoriatic arthritis. Historical background and epidemiology.

  1994cited by this paper
• Natural history of psoriatic arthritis.

  1994cited by this paper
• Historical background and epidemiology

  1994cited by this paper
• PSORIATIC ARTHRITIS (PA): A CLINICAL, IMMUNOLOGICAL AND RADIOLOGICAL STUDY OF 180 PATIENTS

  1991cited by this paper
• A re-evaluation of the osteoarticular manifestations of psoriasis.

  1991cited by this paper
• Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients.

  1991cited by this paper
• Psoriasis and arthritis.

  1990cited by this paper
• Psoriatic arthritis (PSA)--an analysis of 220 patients.

  1987cited by this paper
• HLA antigens in psoriatic arthritis.

  1986cited by this paper
• Psoriasis and arthritis

  1984cited by this paper
• Psoriatic arthritis in psoriatic patients.

  1984cited by this paper
• The nail dystrophy of psoriatic arthritis.

  1979cited by this paper
• Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients.

  1979cited by this paper
• Follow-Up Study

  1977cited by this paper
• Psoriatic arthritis. Follow-up study.

  1976cited by this paper
• PSORIATIC ARTHRITIS.

  1965cited by this paper
• Psoriasis and Arthritis

  1956cited by this paper

• Budget Impact of Secukinumab in Psoriatic Arthritis Patients with Contraindication to TNF-Alpha Inhibitors.

  2026cites this paper
• The path to interception in psoriatic disease: from conceptual clarity to clinical translation.

  2026cites this paper
• Economic Evaluation and Budget Impact Analysis of Secukinumab as a Second-Line Treatment Among Patients With Psoriatic Arthritis Who Were Tumor Necrosis Factor Inadequate Responders in Thailand.

  2026cites this paper
• Investigating the role of serum human beta defensin-2 in psoriasis and psoriatic arthritis: a case-control study on hBD-2 and CRP, ESR.

  2026cites this paper
• Serum calprotectin: could it be a biomarker for disease activity and radiological severity in psoriatic arthritis patients under biological therapy?

  2026cites this paper
• Doppler ultrasonography on small joints of hands and feet to assess subclinical affection in patients with psoriasis

  2026cites this paper
• Perceptions over biologics for psoriasis after 5 years of access in Brazil: a cross-sectional study.

  2026cites this paper
• Dysregulation of caspase-8 and caspase-9 in T-lymphocyte apoptosis: implications for pathogenesis, diagnosis, and therapeutic targeting in psoriatic arthritis

  2026cites this paper
• Autoantibody profile in patients with psoriatic arthritis before and after bdMARD therapy

  2026cites this paper
• Composite and pragmatic measures in psoriatic arthritis: bridging trials and clinical feasibility.

  2026cites this paper
• Patterns of spinal new bone formation in patients with axial spondyloarthritis, psoriatic arthritis, rheumatoid arthritis and healthy controls: a low-dose CT study

  2026cites this paper
• Convergence of Psoriatic Arthritis and Hyperuricemia: A Review of Emerging Data from This New Concept Called “Psout”

  2025cites this paper
• Real-World Effectiveness and Tolerability of Apremilast in Psoriatic Arthritis in Germany: Results from LAPIS-PsA

  2025cites this paper
• Secular trends in biologic prescribing for psoriasis and psoriatic arthritis, 2014–2024

  2025cites this paper
• Psoriatic arthritis and related spondylarthritides

  2025cites this paper
• Prevalence of Psoriatic Arthritis in Patients with Moderate-to-Severe Psoriasis in the Era of Biologics and Small Molecule Therapies

  2025influential citation
• Sternoclavicular joint involvement in psoriatic arthritis: a hidden indicator of disease severity.

  2025cites this paper
• The concept of severity in psoriatic arthritis: a scoping review of the literature.

  2025cites this paper
• Psoriatic Arthritis Characteristics and Comorbidities in North Africa: Results of a Multicenter Retrospective Study.

  2025cites this paper
• Expert consensus on early diagnosis and treatment of psoriatic arthritis (2025 edition)

  2025cites this paper
• Impaired cardiorespiratory fitness in psoriatic arthritis: insights from cardiopulmonary exercise testing

  2025cites this paper
• Weighing in on Obesity and Psoriatic Arthritis - Time to move beyond association to robust randomised trials.

  2025cites this paper
• Effectiveness and Safety of Upadacitinib in Treating Oligoarticular and Polyarticular Psoriatic Arthritis: Primary Analysis from the UPJOINT-Study

  2025cites this paper
• Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology.

  2025cites this paper
• Verlauf der psoriatischen Erkrankung: Prävention der Psoriasis-Arthritis möglicherweise bald greifbar

  2025cites this paper
• An integrated multi-omics analysis identifies protein biomarkers and potential drug targets for psoriatic arthritis

  2025cites this paper
• Access to rheumatologic care in tropical regions: Barriers and solutions.

  2025cites this paper
• Fatigue among psoriatic arthritis patients: validity of the Arabic version of the FACIT-F questionnaire

  2025cites this paper
• Psychological Health in the Management of Patients with Psoriatic Arthritis: An Intricate Relationship

  2025cites this paper
• What are mice teaching us about psoriatic arthritis?

  2025cites this paper
• Physical inactivity and other cardiovascular risk factors in patients with psoriatic arthritis: Do we really “kill two birds with one stone” by managing inflammation?

  2025influential citation
• Janus Kinase Inhibitors As Emerging Therapy in the Treatment of Psoriatic Arthritis: A Narrative Review of Efficacy, Safety, and Future Perspective

  2025cites this paper
• Factors Associated With Diagnosing Psoriatic Arthritis: A Retrospective Study in Northeast Georgia

  2025cites this paper
• Co-occurrence of endometriosis with psoriasis and psoriatic arthritis: Genetic insights (Review)

  2025influential citation
• Real-World Effectiveness of Bimekizumab in Predominantly Difficult-to-Treat Patients with Psoriatic Arthritis Followed in a Combined Dermatology–Rheumatology Clinic: A 24-Week Multicenter Study

  2025cites this paper
• Inhibition of structural damage progression with the selective interleukin-23 inhibitor guselkumab in participants with active PsA: results through week 24 of the phase 3b, randomised, double-blind, placebo-controlled APEX study.

  2025cites this paper
• Characterising Alternative Diagnoses to Psoriatic Arthritis in a Rheumatology‐Dermatology Combined Clinic

  2025cites this paper
• The relationship between vitamin D receptor (VDR) genomic polymorphisms, disease activity, and functional ability in patients with psoriatic arthritis

  2025cites this paper
• Microvascular evaluation in MSK ultrasound

  2025cites this paper
• Medication utilization patterns among patients with rheumatoid arthritis and coexisting autoimmune conditions.

  2025cites this paper
• Effect of a self-management intervention for newly diagnosed inflammatory arthritis: study protocol for a randomized controlled trial

  2025cites this paper
• Late-onset psoriatic arthritis: data from a nationwide cross-sectional study

  2025cites this paper
• Clinical and ultrasound features of a cohort of psoriasis patients without musculoskeletal symptoms: a prospective and multicentre study

  2025cites this paper
• Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease.

  2025cites this paper
• Downregulation of Mitophagy, Complex I Biogenesis, and Signaling by ROBO Receptors—Implications for Psoriasis Pathogenesis

  2025cites this paper
• Pharmacoeconomic study of active psoriatic arthritis treatment

  2025cites this paper
• Long‐Term Real‐World Safety Profile of Secukinumab Assessed Through a 9‐Year Experience in Patients Affected by Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Results From a Multicentric Retrospective Study

  2025cites this paper
• Combining Clinical, Genetic and Protein Markers Using Machine Learning Models Discriminates Psoriatic Arthritis Patients From Those With Psoriasis

  2025cites this paper
• Methodological limitations and cross‐population validation needs in plasma proteomic studies of osteoarthritis risk: comment on the article by Kang et al

  2025cites this paper
• The ‘totality of evidence’ and ‘extrapolation’ of SB17, a ustekinumab biosimilar

  2025cites this paper
• FGF7 as an essential mediator for the onset of ankylosing enthesitis related to psoriatic dermatitis

  2025cites this paper
• Prevalence of psoriatic arthritis in Italy: insights from the multicentric MAPSI study

  2025cites this paper
• A self-management intervention for newly diagnosed with inflammatory arthritis: a randomized controlled feasibility and fidelity study

  2025cites this paper
• Longitudinal risk of serious infections in patients with inflammatory arthritis on immunomodulating therapy compared to controls

  2025cites this paper
• Evaluation of Chat Generative Pretrained Transformer’s Responses to Frequently Asked Questions about Psoriatic Arthritis: A Study on Quality and Readability

  2025cites this paper
• Improvement in Hand Joint Flexibility Following Upadacitinib Treatment of Palmoplantar Pustulosis in Adolescents

  2025cites this paper
• Secukinumab Persistence in Patients with Psoriatic Arthritis: An Adalimumab-Matched Retrospective Cohort Database Study (FLYWAY)

  2025cites this paper
• Delineating inflammatory from non-inflammatory mechanisms for therapy optimization in psoriatic arthritis

  2025cites this paper
• From Diagnosis to Treatment: A Review of AI Applications in Psoriasis Management

  2025cites this paper
• Validation of patient-reported outcome measures for dactylitis, psoriatic skin and nail disease, and uveitis in patients with psoriatic arthritis in routine care

  2025cites this paper
• Comparative Efficacy and Safety of Different Regimens of Current JAK Inhibitors in Psoriatic Arthritis: A Network Meta-analysis.

  2025cites this paper
• Weighing in on Obesity and Psoriatic Arthritis - Time to move beyond association to robust randomised trials.

  2025influential citation
• Are Systemic Drug Choices for Psoriasis by Dermatologists Compatible with Psoriatic Arthritis? Data from the German National Psoriasis Registry PsoBest

  2025cites this paper
• The Effect of Biological Therapies on Psoriasis and Its Associated Comorbidities – New Facts and Future Options

  2025cites this paper
• Identifying characteristics for a cost-effective psoriatic arthritis biomarker test: a development-focused health technology assessment

  2025cites this paper
• A six-month weight loss intervention is associated with significant changes in serum biomarkers related to inflammation, bone and cartilage metabolism in obese patients with psoriatic arthritis and matched controls

  2025cites this paper
• The Pathophysiology of Coronary Artery Disease

  2025cites this paper
• The concordance of swelling/tenderness with ultrasound-detected inflammatory lesions in patients with psoriatic arthritis

  2025cites this paper
• What Are the On‐Ramps to Predict Psoriatic Arthritis? Does Monitoring C‐Reactive Protein Levels Help?

  2025cites this paper
• Physical fitness and physical activity in psoriatic arthritis: a systematic review

  2025cites this paper
• Short-Chain Fatty Acids and Their Role in Modulating Autoimmune Responses in Psoriasis: Insights from Recent Microbiota Research.

  2025cites this paper
• Real-world use of biologic and targeted synthetic disease-modifying antirheumatic drugs in US patients with psoriatic arthritis: Persistence, patient characteristics associated with discontinuation, and dosing patterns.

  2025cites this paper
• Features of the of psoriatic arthritis course in patients with hyperuricemia or gout

  2025cites this paper
• Familial Aggregation in Psoriatic Arthritis: Phenotypic Differences in Patients With and Without a Family History of Psoriatic Disease

  2025cites this paper
• Toward Harmonized Recommendations for Psoriatic Arthritis: A Comparative Viewpoint on Global Guidelines

  2025cites this paper
• Sociodemographic factors and biologic therapy exposure impacting health-related quality of life in psoriatic arthritis - findings from a nationwide registry Reuma.pt

  2025cites this paper
• Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies

  2025cites this paper
• Validation of Turkish psoriatic arthritis screening tool for psoriatic arthritis: A cross-sectional comparative study

  2025cites this paper
• Dose reduction and discontinuation of conventional synthetic disease‐modifying anti‐rheumatic drugs (DMARDs) for people with rheumatoid arthritis or psoriatic arthritis in remission or low disease activity

  2025cites this paper
• Detailed assessment of axial and peripheral entheses and joints in axial spondyloarthritis and psoriatic arthritis patients treated with ixekizumab (DAPHNE): design of a 2-year phase IV trial applying whole-body MRI, MRI-based synthetic CT, and CT

  2025cites this paper
• Cost-Utility Analysis and Comparative Effectiveness Analysis of Biologic Treatment of Moderate-to-Severe Psoriasis in Saudi Arabia

  2024cites this paper
• Elevating the Standard of Care for Patients with Psoriatic Arthritis: ‘Calls to Action’ from a Multistakeholder Pan-European Initiative

  2024cites this paper
• Predictors of response to bDMARDs and tsDMARDs in psoriatic arthritis: a pilot study on the role of musculoskeletal ultrasound

  2024cites this paper
• Rheumatology and Dermatology Multidisciplinary Clinic Improves Diagnostic Precision and Treatment Decisions in Patients Suspected or Diagnosed with Psoriatic Arthritis

  2024cites this paper
• Tuberculous spondylitis: Macromorphological and radiological studies on a skeleton from the Late Iron Age monument of Nor Armavir, Armenia

  2024cites this paper
• Impact of disease, musculoskeletal symptoms and disease control in the CorEvitas Psoriasis Registry.

  2024cites this paper
• Relationship Between Family History and Quality of Life in Patients with Psoriasis: A Cross-Sectional Study from China

  2024cites this paper
• The Effect of JAK Inhibitors on Patient-Reported Outcomes in Psoriatic Arthritis

  2024cites this paper
• Effect of bimekizumab on patient-reported disease impact in patients with psoriatic arthritis: 1-year results from two phase 3 studies

  2024cites this paper
• Psoriasis treatments in the stabilization of atherosclerosis: a systematic review

  2024cites this paper
• Evaluation of diagnostic and therapeutic delay in patients with rheumatoid arthritis and psoriatic arthritis.

  2024cites this paper
• Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial

  2024cites this paper
• Nature and Treatment Received for Psoriasis and Co-morbidities in Patients with Psoriatic Arthritis. A Multi-centre Observational Study from Western India

  2024cites this paper
• Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia

  2024influential citation
• NJK14047 inhibition of p38 MAPK ameliorates inflammatory immune diseases by suppressing T cell differentiation.

  2024cites this paper
• Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial

  2024cites this paper
• Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage

  2024cites this paper
• Ultrasound Assessment of Psoriatic Arthritis Patients With Clinically Normal Nails and Evaluation of its Correlation With the Disease Activity

  2024cites this paper
• Effectiveness of secukinumab in patients with psoriasis and psoriatic arthritis in a Saudi real-world setting

  2024influential citation
• Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study

  2024cites this paper